
Discovery of 'weak spot' in COVID-19 variants could lead to better treatment options
CTV
A discovery by a team of B.C. researchers may lead to improved COVID-19 treatment options that are effective against several variants of the disease.
A discovery by a team of B.C. researchers may lead to improved COVID-19 treatment options that are effective against several variants of the disease.
Researchers at the University of British Columbia say they've found a "weak spot" in COVID-19 variants, including in the latest Omicron subvariants. Their findings were published in Nature Communications on Thursday.
"This is a highly adaptable virus that has evolved to evade most existing antibody treatments, as well as much of the immunity conferred by vaccines and natural infection," said Dr. Sriram Subramaniam, a professor at UBC's faculty of medicine and the study's senior author, in a news release.
"This study reveals a weak spot that is largely unchanged across variants and can be neutralized by an antibody fragment. It sets the stage for the design of pan-variant treatments that could potentially help a lot of vulnerable people."
The researchers, who worked with a team from the University of Pittsburgh, explained that while antibody treatments have been available for COVID-19, some are less effective against muted variants like Omicron.
"Antibodies attach to a virus in a very specific manner, like a key going into a lock. But when the virus mutates, the key no longer fits," Subramaniam explained.
"We've been looking for master keys — antibodies that continue to neutralize the virus even after extensive mutations."

At a large Toronto supermarket known for its Iranian and Middle Eastern staples, shelves remain full of customers’ favourites—at least for now. But the store’s longtime operator warns that could change later this year as the war in the Middle East disrupts some food supplies and drives up global prices.












